×
Pending review
Seguir

Olanib 150 mg (Olaparib)

Community

SECTORES

WEB OFICIAL

About Olanib 150 mg (Olaparib)

Olanib 150 mg, containing the active ingredient olaparib, is a targeted cancer therapy primarily used for treating specific types of ovarian, breast, pancreatic, and prostate cancers. Olaparib belongs to a class of drugs known as PARP inhibitors, which work by preventing cancer cells from repairing their DNA, leading to cell death. It's particularly effective in patients with BRCA1 or BRCA2 gene mutations. The medication is typically administered orally and requires careful monitoring for potential side effects, including nausea, fatigue, anemia, and leukopenia. Regular follow-ups with a healthcare provider are crucial to ensure optimal treatment outcomes and manage any adverse effects.

Image Gallery Olanib 150 mg (Olaparib) 0

Olanib 150 mg (Olaparib) doesn't have any images in his gallery.

Data Olanib 150 mg (Olaparib)

Offices
Locations

Equipo Olanib 150 mg (Olaparib) 1

Noticias Olanib 150 mg (Olaparib) 0

Olanib 150 mg (Olaparib) no tiene ninguna noticia disponible.

Cookies policy We use proprietary and third-party cookies to improve our services and user experience. If you continue to browse, we believe you accept its use.

Accept